Enalapril doesn’t directly improve oxygenation in pulmonary hypertension but can lower blood pressure and ease heart strain, potentially enhancing overall condition management.

Enalapril is primarily an antihypertensive and may indirectly benefit pulmonary hypertension management by reducing cardiac workload, but isn’t a frontline treatment for improving oxygenation.

While Enalapril helps manage left heart dysfunction in pulmonary hypertension, it doesn’t specifically target oxygen levels. Used with other treatments, it can aid in overall cardiovascular health.